M.tb PE_PGRS Acts as an Immunological Decoy: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Subjects: Immunology
Contributor:
Seyed Hasnain

Mycobacterium tuberculosis (M.tb) is a successful pathogen that can reside within the alveolar macrophages of the host and can survive in a latent stage. The pathogen has evolved and developed multiple strategies to resist the host immune responses. M.tb escapes from host macrophage through evasion or subversion of immune effector functions. M.tb genome codes for PE/PPE/PE_PGRS proteins, which are intrinsically disordered, redundant and antigenic in nature. These proteins perform multiple functions that intensify the virulence competence of M.tb majorly by modulating immune responses, thereby affecting immune mediated clearance of the pathogen. The highly repetitive, redundant and antigenic nature of PE/PPE/PE_PGRS proteins provide a critical edge over other M.tb proteins in terms of imparting a higher level of virulence and also as a decoy molecule that masks the effect of effector molecules, thereby modulating immuno-surveillance. An understanding of how these proteins subvert the host immunological machinery may add to the current knowledge about M.tb virulence and pathogenesis. This can help in redirecting our strategies for tackling M.tb infections.

  • decoy antigens
  • glycine
  • immune evasion
  • latency
  • pathogenicity
  • TB
  • virulence

1. Introduction

Tuberculosis (TB), caused by the opportunistic pathogen Mycobacterium tuberculosis (M.tb), is a deadly disease and a major cause of death globally, [1] The prognosis of TB is further worsened due to co-morbid conditions, such as infections of HIV, and now the ongoing COVID-19 pandemic is posing additional challenges [2]. The emergence of drug resistant forms (MDR and XDR) of M.tb is a cause of concern as it has slowed our efforts to eradicate TB worldwide [3]. Macrophages are primarily efficient in clearing pathogens; however, M.tb can survive intracellularly within the niche of macrophage itself. M.tb has evolved various mechanisms that allow it to hijack the process of phagosome-lysosome fusion, inhibit acidification of phagosome, suppress autophagy and apoptosis pathways used by macrophage for the clearance of pathogens [4][5][6][7]. M.tb overpowers the extremely microbicidal nature presented within the macrophages through a multifaceted and complex interplay between its proteins and host immune responses [8][9]. Several M.tb proteins have been reported to evoke innate and adaptive immune responses, though many of these act as decoy antigens to subvert the immune system. Decoy antigens mimic host-pathogen effector components and can misdirect the immune response pathways that favor the survival of the pathogen. Pathogenic bacteria such as M.tb also use decoy proteins as a generic mechanism to mask themselves from immune surveillance, thereby evading and subverting host immune responses [10][11]. The decoy antigens can be classified into three broad categories, namely, receptor, bodyguard and sensing decoys. As the name suggests, receptor decoys are employed by the pathogens to modulate host immune signaling pathways. In contrast, bodyguard decoys act as inactive mimics to safeguard the virulence factors of pathogens from the host response. Sensing decoys mimic the effector functions of the target proteins of both the host and the pathogens [12].
The mycobacterial PE/PPE/PE_PGRS protein family, present only in the genus mycobacterium and nowhere else in the living kingdom, occupies approximately 10% of the coding capacity of the M.tb genome. Despite the reductive genomic evolution of M.tb [13], the PE/PPE/PE_PGRS family of genes has been expanding during mycobacterial evolution. The presence of this family only in pathogenic strains of the genus mycobacterium, such as M.tb, M.marinum and M.bovis, points to its likely importance in disease pathogenesis [14]. The evolution of PE/PPE gene families was found to be associated with the ESX secretion system [15], and proteins were majorly reported to be either surface exposed or secreted [16][17][18]. Cell-surface localization of PE/PPE/PE_PGRS proteins may serve an important function in host-pathogen interactions and in the virulence and pathogenesis of M.tb [19]. PE_PGRS (polymorphic GC-rich sequences) proteins are a subclass of the PE protein family and consists of a highly conserved N-terminal (approx. 110 amino acid long) the PE domain followed by the C-terminal domain harboring multiple repeats of Gly-Gly-Ala or Gly-Gly-Asn. Deciphering the role of proteins belonging to the PE_PGRS family may reveal new aspects of the biology of M.tb. The presence of multiple tandem repeats of GGA or GGN has been attributed to cause antigenic variations and aid in immune evasion mechanisms, thereby facilitating pathogen survival. The repetitive nature of PE_PGRS proteins and their surface localization both lead to the generation of immune responses by macrophages and may aid in immune subversion [17].

2. Immune Evasion and Subversion Properties of PE_PGRS Proteins: A Possible Reflection of Antigenic Variation, Disordered Nature and Glycine Content

During the course of evolution, pathogenic bacteria developed multiple strategies to avoid or subvert host machinery, especially the mechanisms that drive protective outcomes of host immune response [20][21]. Pathogens also manipulate the outcome of the host’s immune response by altering antigen presentation pathways and engaging host immune machinery with multiple antigens [22][23]. M.tb utilize extremely progressive and harmonized mechanisms of immune evasion that divert or subvert the host proteins involved in neutralizing the virulence of the pathogen. In doing so, the host machinery gets engaged in evoking immune responses against the decoy antigens, thereby neutralizing the efficacy of host immune response in bacterial clearance [10][11]. Multiple PE_PGRS proteins evoke different signals that allow the pathogen to evade the host immune response [24]. PGRS domain of PE_PGRS62 protects the PE protein from ubiquitin-proteasome mediated degradation and also affects the ability of the CD8+ T-cells to recognize the protein, thereby conferring protection to the pathogen present within the macrophages [25].
Several pathogens employ intrinsically disordered proteins (IDPs) or disordered short stretches for a variety of moonlighting functions [26][27][28]. IDPs, by virtue of their conformational plasticity and short interaction motifs, can interact with different protein partners [29]. Such disordered effector proteins perturb host cellular cascades via favorable interactions through molecular mimicry in both viruses and bacteria [27][28][30]. The PGRS domain of PE_PGRS proteins lacks a definite three-dimensional (3D) structure and is intrinsically disordered in nature [16][31][32][33]. The transition from an ordered to a disordered state or vice versa will serve to hijack host immune machinery for subsequent survival of the pathogen [13][16][34].
The generation of antigenic variation is one of the passive mechanisms of immune evasion and subversion [35][36]. PE/PPE/PE_PGRS proteins are known to provide a major source of antigenic variations in M.tb and its clinical isolates [17][37]. Thus, their prospective importance in acting as a decoy antigen to the host is emphasized. The interaction of M.tb with macrophage offsets the Ca2+ signaling that causes abnormality in phagosome maturation. Ca2+ binds with the PE_PGRS33 and PE_PGRS61 proteins [24][38]. These calcium dependent PE_PGRS proteins decrease the Ca2+ concentration during the initial phase of non-specific attachment of M.tb with the alveolar macrophages. The decrease in the Ca2+ in the macrophage suppresses the phagolysosomal fusion of the M.tb with the acidic lysosome; thereby contributing to the survival of the M.tb. PE_PGRS 33 and PE_PGRS41 are cell wall associated proteins. While the PE domain of the PE_PGRS 33 is important for cellular localization, the PGRS domain of this protein is important for cellular morphology of the bacterium and its entry within the host cells. Knock-in of the PE_PGRS33 gene in M smegmatis imparts endurance to the bacterium to overcome the cytotoxic effect of the macrophage and enhances the level of TNF. Although M smegmatis does not effectively infect host cells, recombinant strains of M smegmatis expressing PE_PGRS33 can colonize the lungs, spleen and liver, which is a typical feature for virulent M tuberculosis [34]. Ramakrishnan et al. showed that pathogenic M.marinum expresses two proteins (mag 24 and mag 85) that are homologous with M.tb PE_PGRS protein family, and are involved in granuloma formation and the replication of the pathogen within the macrophage [39]. Mice immunized with the PE domain of the PE_PGRS 33 exhibit a higher cell-mediated response while immunization with the complete PE_PGRS 33 leads to increased humoral response [40]. These studies also suggest that differential expression and the regulation of PE/PE_PGRS protein family during M.tb infection play a key role in enhancing the virulence features of the pathogen.
The VaxiJen antigenicity prediction tool shows a high antigenicity index for PE_PGRS proteins (Figure 1). The antigenicity index of PE_PGRS proteins increases as a direct function of the glycine content of these proteins (Figure 2). PGRS domain of PE_PGRS proteins was observed to be highly rich in glycine, with major chunks of Gly-Gly-Ala stretches similar to EBNA-1 antigen [25]. Glycine, a highly conserved amino acid, is known to initiate several protective and immunomodulatory responses in the host cells. Glycine modulates the function of the macrophage and evokes inflammatory cytokines, as compared to other amino acids [41]. Cell wall proteins that are rich in glycine exhibit greater antigenicity and are notable targets in several autoimmune and food borne allergies. It is important to note that the presence of high glycine content in proteins with high antigenicity indices is not just a matter of chance but points to the role of glycine-rich proteins in non-specific but targeted protective immune responses from host macrophages.
Ijms 23 00525 g001 550
Figure 1. (A) Antigenicity index of PE_PGRS proteins of M.tb, as predicted by antigenicity prediction tool VaxiJen. (B) Glycine content of PE_PGRS proteins of M.tb calculated by ExpasyProtParam tool. All values were plotted in increasing order of their magnitude.
Ijms 23 00525 g002 550
Figure 2. Antigenicity index of PE_PGRS proteins increases with increase in glycine content of PE_PGRS proteins. Antigenicity index was plotted against glycine percentage in linear ratio.
The role of PE_PGRS proteins in the immune evasion mechanism is attributed to varied and diverse patterns of the cytokine profile during M.tb infections [42]. While some of the PE_PGRS family of proteins, such as PE_PGRS5, PE_PGRS11, PE_PGRS17 and PE_PGRS30, evoke pro-inflammatory responses; others such as PE_PGRS26 are known to induce anti-inflammatory responses. This shows that PE_PGRS have contrasting roles in immune response and can act as a molecular switch for skewing the response as pro-host or pro-pathogen during tuberculosis [14][37]. The partial homology of PE-PGRS with EBNA domain of the Epstein–Barr virus speculates that it may play a role in the evasion of cytotoxic T-cell response to inhibit antigen processing [40][43].
Protein antigens are processed through the MHC (major histocompatibility complex) class I and MHC class II. MHC I is ubiquitously expressed on nucleated cells whereas MHC II is expressed on antigen presenting cells (APCs) including macrophages, dendritic cells, etc. Within the macrophage, M.tb secreted proteins are processed into smaller peptides and presented through the MHC II to the T-cells [44]. The proteins are processed through the proteasomal degradation machinery of the cell, which are translocated to the endoplasmic reticulum through the transporters associated with antigen processing (TAP) proteins [45]. CD4+ T cells recognize these processed antigens primed on the MHC II leading to the generation of effector and memory T-cell response against the antigenic peptides. M.tb involves multiple mechanisms to prevent or bypass antigen presentation processes (pathways) by inhibiting the truncation of secreted proteins into 8–25 amino acid long short peptides, required for the MHC II pathway [10][44][46]. Phagosomes, the main component of the MHC class II mediated classical antigen presentation pathway is a critical spot within the macrophages that is hijacked by the M.tb, resulting in inhibition of the proteasomal processing of secreted antigens. Thus, M.tb antigens within the macrophage are masked from being recognized by the T-cells, thereby protecting M.tb from cellular immune response [47]. PE/PPE/PE_PGRS proteins could be expressed as the early immunodominant antigens followed by the other functionally dominant but immuno-subdominant virulence factors. PE_PGRS proteins neutralize the effector functions of the host immune system, thereby acting as “decoy” for allowing the safe passage of other important effector molecules of the pathogen within the internal proximity of the host. Effector T cells primed against the decoy immunogen search for similar antigens throughout the cells of the host, which are discontinued by the pathogen during a subsequent phase of infection. In this way, the dominant virulent factors of M.tb remain unaffected by the cell-mediated immune response. The consequent subversion of T-cell response allows the bacteria to successfully establish its pathogenicity and disease progression within the host [48].
Several members of the PE_PGRS protein family were shown to induce a wide range of contradictory T-cell and B-cell responses as described in earlier sections [49]. Such responses are not specific to this protein family, rather a generalized and diverse immune profile have been observed [42]. PE_PGRS11 and PE_PGRS17 proteins are involved in the activation and maturation of human dendritic cells and boost pro-inflammatory responses [50]. The PE and PGRS domain of PE_PGRS33 evoke different immune response against M.tb. Mice immunized with PE domain of Rv1818c elicited cellular responses and IFN-γ production, while the humoral response was induced upon immunization with the PGRS domain and not by the PE domain alone [40]. Another study showed the generation of B-cell responses against the PGRS domain of PE_PGRS33 [51]. M.smegmatis over-expressing PE_PGRS33 and PE_PGRS26 show enhanced production of IL-10 cytokine levels in macrophage cell lines [52]. An anti-inflammatory response of macrophages due to the PE_PGRS30 protein in terms of the reduced production of IL-12, TNF-α and IL-6 was reported [53]. PE_PGRS33 is linked with the increased production of TNF-α and IL-10, and reduced levels of IL-12p40 [54]. In contrast, the expression of PE_PGRS16 enhances IL-12p40 levels but reduces IL-10 cytokine production [52]. The immune response generated by PE_PGRS16 was antagonistic to that of PE_PGRS26 [52][55]. These studies show that the PGRS domain plays a key role in PE_PGRS proteins and is an important target for manipulating immune response.
The elicitation of antibody responses specifically directed against the glycine and asparagine repeats has been reported [56]. PPE18 and some other 20 PE proteins have been shown to generate CD4 or CD8 mediated T-cell responses [57]. Th-2 responses and reduced IFN-Υ levels have been detected against PPE44 protein of M.tb [58]. PGRS domain of PE_PGRS5 protein induce TNF-α and IL-12 cytokines in macrophages [59] in a calcium dependent manner [60].
One of the most widely used anti-TB vaccine strains, BCG, is not fully capable of secreting a class of PE/PPE family proteins (specifically PE_PGRS and PPE-MPTR) due to the absence of the RD5-genetic region (containing functional Esx-5 and PPE38/71 involved in secretion) [61]. The BCG vaccine elicits a reduced repertoire of antigens during infection. In order to assess the immunogenic potential of PE/PPE/PE_PGRS proteins, Ates et al. restored the BCG strain with PPE38 locus, which improved the PE_PGRS and PPE_MPTR secretion in infected mice. Restoration of PE_PGRS and PPE_MPTR secretion neither enhanced the activation of immune cells nor boosted the protective efficacy of the restored BCG mutant strain [61]. Further studies are warranted to reveal the role of PGRS domain in improving the efficacy of recombinant BCG.
To summarize, these observations show that PE PGRS proteins have a variety of contrasting implications, not simply the PGRS domain, which may aid in evasion and modification of immune effector activities, and hence undermine the targeting of other critical mycobacterial pathogenic proteins (Figure 3 and Figure 4). This subversion may influence the course of disease pathogenesis and lead to higher survival rates of M.tb within alveolar macrophages. These observations are a pointer to reconsider the immunomodulatory effects of PE/PPE/PE_PGRS proteins (Table 1, Table 2, Table 3 and Table 4), few of which are considered in vaccine formulations. Understanding the mechanisms of the PE/PE_PGRS family of proteins in evading and subverting immune responses may aid in targeting these proteins for future therapeutic interventions.
Ijms 23 00525 g003 550
Figure 3. M.tb PPE_PGRS antigens play a role of virulent determinants by acting as an immunological decoy to capture the host immune machinery and evoke varied immune responses. This aids in evasion and subversion of host immune cellular functions during M.tb infection.
Ijms 23 00525 g004 550
Figure 4. PE/PPE proteins augment the immune system of the host using decoy strategies. M.tb infection is most commonly found in macrophages, where the pathogen is endocytosed and transported to the endosome compartment. M.tb secretes non-PE/PPE and PE/PPE proteins along with other effector molecules. PE/PPE proteins are involved in the activation of immune cells. These proteins, according to the immune system, pose the greatest hazard to the cellular system. Other non-PE/PPE effectors, on the other hand, infiltrate the system and take control of the machinery, inflicting severe damage and pathogenicity.
Table 1. Comprehensive table showing role of different PE proteins in immune modulation of host.
Sr. No. PE Proteins Role in Immune Modulation Reference
1. PE17
  • Through JNK signaling, it regulates the transcription of pro/anti-inflammatory cytokines
 [62][63]
  • Increases macrophage apoptosis via chromatin remodeling in the host
2. PE6
  • TLR-4 agonist
  • Pro-inflammatory cytokines are stimulated
 [64][62]
3. PE31
  • Inhibits apoptosis
  • Pro-inflammatory cytokine production is inhibited
  • Anti-inflammatory cytokines are stimulated
 [64][65]
4. PE13
  • Increases pro-inflammatory cytokines secretion
  • Promotes macrophage apoptosis
 [66]
5. PE27
  • Increases pro-inflammatory cytokines secretion
  • Contributes to Th-1-biased response
 [67]
6. PE11
  • Induces necrotic macrophage death
  • Decreased the levels of IL-6 cytokine in macrophages
 [68]
7. PE5
  • Reduces the release of pro-inflammatory cytokines
  • Increases the production of anti-inflammatory cytokines
 [69]
8. PE15
  • Reduces the release of pro-inflammatory cytokines
  • Increases the production of anti-inflammatory cytokines
 [69]
Table 2. Comprehensive table showing role of different PPE proteins in host immune modulation.
Sr. No. PPE Proteins Role in Immune Modulation Reference
1. PPE18
  • Antigen presentation by MHC class II antigens is inhibited
  • B-cell response is inhibited
 [70]
2. PPE65
  • TLR-2 agonist
  • Pro-inflammatory cytokines are stimulated
 [71]
3. PPE57
  • TLR-2 agonist
  • Contributes to Th1-biased response
 [72]
4. PPE26
  • Increases the pro-inflammatory cytokines.
  • TLR-2 agonist.
  • Contributes to Th1-biased response.
 [73]
5. PPE60
  • Initiates macrophage pyroptosis via caspases/NLRP3/gasdermin
  • Pro-inflammatory cytokines are stimulated
  • TLR-2 agonist
  • Activates Th-1/Th-17 responses in macrophages
 [74][75]
6. PPE11
  • Promotes host-cell death
  • Pro-inflammatory cytokines are stimulated
 [76]
7. PPE27
  • Promotes host-cell death
  • The secretion of pro-inflammatory cytokines is manipulated
 [77]
8. PPE44
  • Promotes host-cell death
  • The secretion of pro-inflammatory cytokines is stimulated (IL-12p40 and IL-6)
 [78]
       
9. PPE38
  • Pro-inflammatory cytokines are stimulated
  • Modulates macrophage inflammatory responses through NF-κB signaling
 [79]
10. PPE10
  • Macrophages apoptosis was regulated by reducing the expression of caspases
  • Pro-inflammatory cytokines are stimulated
 [80]
11. PPE32
  • Through ERK1/2 signaling, it boosts the expression of IL-12p40 and IL-32
  • Promotes macrophage apoptosis
 [81]
12. PPE57
  • Enhances the type-I Interferon signaling pathway
 [63]
Table 3. Comprehensive table showing role of different PE-PGRS proteins in host immune modulation.
Sr. No. PE_PGRS Proteins Role in Immune Modulation Reference
1. PE_PGRS41
  • Promotes cytotoxic host-cell death
  • Pro-inflammatory cytokine production is inhibited
 [82]
2. PE_PGRS18
  • Modulates macrophages cytokines secretion
  • Inhibits macrophage apoptosis
 [83]
3. PE_PGRS5
  • TLR-4 agonist
  • ER dependent UPR activation towards stress-mediated apoptosis
  • Pro-inflammatory cytokines are stimulated
 [31][59]
4. PE_PGRS11
  • TLR-2 agonist
  • Pro-inflammatory cytokines are stimulated
  • Dendritic cells are activated, which stimulate CD4+ T-cells
 [50]
5. PE_PGRS17
  • TLR-2 agonist
  • Pro-inflammatory cytokines are stimulated
  • Dendritic cells are activated, which stimulate CD4+ T-cells
 [50]
6. PE_PGRS33
  • TLR-2 agonist
  • Induces the secretion of TNF-α from the macrophages
 [84]
7. PE_PGRS62
  • Latent and active TB patients shows strong antibody response
 [85]
Table 4. Comprehensive table showing role of different PE/PPE paired proteins in host immune modulation.
Sr. No. PE/PPE Proteins Role in Immune Modulation Reference
1. PE32/PPE65
  • Inhibits pro-inflammatory cytokines
  • Enhances anti-inflammatory cytokine
  • Dampens Th1 response
 [86]
2. PE9/PE10
  • TLR-4 agonist
  • Promotes apoptosis in macrophages
 [87]
3. PE25/PPE41
  • Induces necrotic macrophage death
 [88]
4. PE35/PPE68
  • Reduces the release of pro-inflammatory cytokines
  • Increases the production of anti-inflammatory cytokines
 [89]
 

This entry is adapted from the peer-reviewed paper 10.3390/ijms23010525

References

  1. Chakaya, J.; Khan, M.; Ntoumi, F.; Aklillu, E.; Fatima, R.; Mwaba, P.; Kapata, N.; Mfinanga, S.; Hasnain, S.E.; Katoto, P.D.M.C.; et al. Global Tuberculosis Report 2020; Reflections on the Global TB burden, treatment and prevention efforts. Int. J. Infect. Dis. 2021, 11, S1201–9712.
  2. Singh, J.; Ehtesham, N.Z.; Hasnain, S.E. Two parallel pandemics: The challenges faced by countries with COVID-19 and TB. Int. J. Tuberc. Lung Dis. 2020, 24, 1319–1320.
  3. WHO. Global Tuberculosis Report 2019 Geneva. Global Tuberculosis Report 2019; World Health Organization: Geneva, Switzerland, 2020.
  4. Ehrt, S.; Schnappinger, D. Mycobacterial survival strategies in the phagosome: Defence against host stresses. Cell. Microbiol. 2009, 11, 1170–1178.
  5. Meena, L.S. Interrelation of Ca2+ and PE_PGRS proteins during Mycobacterium tuberculosispathogenesis. J. Biosci. 2019, 44, 24.
  6. Nair, S. Immunomodulatory Role of Mycobacterial PE/PPE Family of Proteins. Proc. Ind. Natl. Sci. Acad. 2014, 80, 1055.
  7. Pandey, S.; Tripathi, D.; Khubaib, M.; Kumar, A.; Sheikh, J.A.; Sumanlatha, G.; Ehtesham, N.Z.; Hasnain, S.E. Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Are Immunogenic, Alter Cytokine Profile and Aid in Intracellular Survival. Front. Cell. Infect. Microbiol. 2017, 7, 38.
  8. Gomes, M.S.; Paul, S.; Moreira, A.L.; Appelberg, R.; Rabinovitch, M.; Kaplan, G. Survival of Mycobacterium avium and Mycobacterium tuberculosis in Acidified Vacuoles of Murine Macrophages. Infect. Immun. 1999, 67, 3199–3206.
  9. Meena, L.S. Rajni Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J. 2010, 277, 2416–2427.
  10. Baena, A.; Porcelli, S.A. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 2009, 74, 189–204.
  11. Goldberg, M.F.; Saini, N.K.; Porcelli, S.A. Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis. Microbiol. Spectr. 2014, 2.
  12. Paulus, J.K.; Van Der Hoorn, R.A.L. Tricked or trapped—Two decoy mechanisms in host–pathogen interactions. PLoS Pathog. 2018, 14, e1006761.
  13. Ahmed, N.; Dobrindt, U.; Hacker, J.; Hasnain, S. Genomic fluidity and pathogenic bacteria: Applications in diagnostics, epidemiology and intervention. Nat. Rev. Genet. 2008, 6, 387–394.
  14. Sampson, S.L. Mycobacterial PE/PPE Proteins at the Host-Pathogen Interface. J. Immunol. Res. 2011, 2011, 497203.
  15. Van Pittius, N.C.G.; Sampson, S.L.; Lee, H.; Kim, Y.; Van Helden, P.D.; Warren, R.M. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol. Biol. 2006, 6, 95.
  16. Ahmad, J.; Khubaib, M.; Sheikh, J.A.; Pancsa, R.; Kumar, S.; Srinivasan, A.; Babu, M.M.; Hasnain, S.E.; Ehtesham, N.Z. Disorder-to-order transition in PE–PPE proteins of Mycobacterium tuberculosis augments the pro-pathogen immune response. FEBS Open Bio 2019, 10, 70–85.
  17. Akhter, Y.; Ehebauer, M.T.; Mukhopadhyay, S.; Hasnain, S. The PE/PPE multigene family codes for virulence factors and is a possible source of mycobacterial antigenic variation: Perhaps more? Biochimie 2012, 94, 110–116.
  18. Delogu, G.; Pusceddu, C.; Bua, A.; Fadda, G.; Brennan, M.J.; Zanetti, S. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure. Mol. Microbiol. 2004, 52, 725–733.
  19. Cadieux, N.; Parra, M.; Cohen, H.; Maric, D.; Morris, S.L.; Brennan, M.J. Induction of cell death after localization to the host cell mitochondria by the Mycobacterium tuberculosis PE_PGRS33 protein. Microbiology 2011, 157, 793–804.
  20. Bowie, A.G.; Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8, 911–922.
  21. Finlay, B.B.; McFadden, G. Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens. Cell 2006, 124, 767–782.
  22. Antoniou, A.N.; Powis, S. Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Immunology 2008, 124, 1–12.
  23. Woolard, M.D.; Frelinger, J.A. Outsmarting the host: Bacteria modulating the immune response. Immunol. Res. 2008, 41, 188–202.
  24. Yu, X.; Feng, J.; Huang, L.; Gao, H.; Liu, J.; Bai, S.; Wu, B.; Xie, J. Molecular Basis Underlying Host Immunity Subversion by Mycobacterium tuberculosis PE/PPE Family Molecules. DNA Cell Biol. 2019, 38, 1178–1187.
  25. Koh, K.W.; Lehming, N.; Seah, G.T. Degradation-resistant protein domains limit host cell processing and immune detection of mycobacteria. Mol. Immunol. 2009, 46, 1312–1318.
  26. Mohan, A.; Jr., W.J.S.; Radivojac, P.; Dunker, A.K.; Uversky, V.N. Intrinsic disorder in pathogenic and non-pathogenic microbes: Discovering and analyzing the unfoldomes of early-branching eukaryotes. Mol. BioSyst. 2008, 4, 328–340.
  27. Tompa, P. Intrinsically unstructured proteins. Trends Biochem. Sci. 2002, 27, 527–533.
  28. Via, A.; Uyar, B.; Brun, C.; Zanzoni, A. How pathogens use linear motifs to perturb host cell networks. Trends Biochem. Sci. 2015, 40, 36–48.
  29. Van Der Lee, R.; Buljan, M.; Lang, B.; Weatheritt, R.J.; Daughdrill, G.W.; Dunker, A.K.; Fuxreiter, M.; Gough, J.; Gsponer, J.; Jones, D.T.; et al. Classification of Intrinsically Disordered Regions and Proteins. Chem. Rev. 2013, 114, 6589–6631.
  30. Davey, N.E.; Travé, G.; Gibson, T.J. How viruses hijack cell regulation. Trends Biochem. Sci. 2011, 36, 159–169.
  31. Grover, S.; Sharma, T.; Singh, Y.; Kohli, S.; Manjunath, P.; Singh, A.; Semmler, T.; Wieler, L.H.; Tedin, K.; Ehtesham, N.Z.; et al. The PGRS Domain of Mycobacterium tuberculosis PE_PGRS Protein Rv0297 Is Involved in Endoplasmic Reticulum Stress-Mediated Apoptosis through Toll-Like Receptor 4. mBio 2018, 9, e01017-18.
  32. Ahmad, J.; Farhana, A.; Pancsa, R.; Arora, S.K.; Srinivasan, A.; Tyagi, A.K.; Babu, M.M.; Ehtesham, N.Z.; Hasnain, S.E. Contrasting Function of Structured N-Terminal and Unstructured C-Terminal Segments of Mycobacterium tuberculosis PPE37 Protein. mBio 2018, 9, e01712-17.
  33. Blundell, T.L.; Gupta, M.N.; Hasnain, S.E. Intrinsic disorder in proteins: Relevance to protein assemblies, drug design and host-pathogen interactions. Prog. Biophys. Mol. Biol. 2020, 156, 34–42.
  34. Ehtesham, N.Z.; Ahmad, J.; Farhan, A.; Khubaib, M.; Kaur, S.; Pancsa, R.; Srinivasan, A.; Kumar, S.; Babu, M.; Hasnain, S.E. Intrinsically Disordered Regions/Proteins Compensate for Genomic Economization In Mycobacterium tuberculosis. FASEB J. 2018, 32, 526.23.
  35. Janeway, C.A., Jr.; Travers, P.M.W. Pathogens have evolved various means of evading or subverting normal host defenses. In Immunobiology: The Immune System in Health and Disease, Chapter 11, 5th ed.; Garland Science: New York, NY. USA, 2001.
  36. Mohan, G.S.; Li, W.; Ye, L.; Compans, R.W.; Yang, C. Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus. PLoS Pathog. 2012, 8, e1003065.
  37. Meena, L.S. An overview to understand the role of PE_PGRS family proteins inMycobacterium tuberculosisH37Rv and their potential as new drug targets. Biotechnol. Appl. Biochem. 2014, 62, 145–153.
  38. Yeruva, V.C.; Kulkarni, A.; Khandelwal, R.; Sharma, Y.; Raghunand, T.R. The PE_PGRS Proteins of Mycobacterium tuberculosis Are Ca2+ Binding Mediators of Host–Pathogen Interaction. Biochemistry 2016, 55, 4675–4687.
  39. Ramakrishnan, L.; Federspiel, N.A.; Falkow, S. Granuloma-Specific Expression of Mycobacterium Virulence Proteins from the Glycine-Rich PE-PGRS Family. Science 2000, 288, 1436–1439.
  40. Delogu, G.; Brennan, M.J. Comparative Immune Response to PE and PE_PGRS Antigens of Mycobacterium tuberculosis. Infect. Immun. 2001, 69, 5606–5611.
  41. Zhong, Z.; Wheeler, M.D.; Li, X.; Froh, M.; Schemmer, P.; Yin, M.; Bunzendaul, H.; Bradford, B.; Lemasters, J.J. L-Glycine: A novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr. Opin. Clin. Nutr. Metab. Care 2003, 6, 229–240.
  42. Medha, L.S.; Sharma, S.; Sharma, M. Proline-Glutamate/Proline-Proline-Glutamate (PE/PPE) proteins of Mycobacterium tuberculosis: The multifaceted immune-modulators. Acta Trop. 2021, 222, 106035.
  43. Cole, S.T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S.V.; Eiglmeier, K.; Gas, S.; Barry, C.E.; et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 396, 190.
  44. Harding, C.V.; Boom, W.H. Regulation of antigen presentation by Mycobacterium tuberculosis: A role for Toll-like receptors. Nat. Rev. Genet. 2010, 8, 296–307.
  45. Grotzke, J.E.; Siler, A.C.; Lewinsohn, D.A.; Lewinsohn, D.M. Secreted Immunodominant Mycobacterium tuberculosis Antigens Are Processed by the Cytosolic Pathway. J. Immunol. 2010, 185, 4336–4343.
  46. Bettencourt, P.; Müller, J.; Nicastri, A.; Cantillon, D.; Madhavan, M.; Charles, P.D.; Fotso, C.B.; Wittenberg, R.; Bull, N.; Pinpathomrat, N.; et al. Identification of antigens presented by MHC for vaccines against tuberculosis. Vaccines 2020, 5, 1–14.
  47. Winslow, G.M.; Cooper, A.; Reiley, W.; Chatterjee, M.; Woodland, D.L. Early T-cell responses in tuberculosis immunity. Immunol. Rev. 2008, 225, 284–299.
  48. Bold, T.D.; Banaei, N.; Wolf, A.J.; Ernst, J.D. Suboptimal Activation of Antigen-Specific CD4+ Effector Cells Enables Persistence of M. tuberculosis In Vivo. PLoS Pathog. 2011, 7, e1002063.
  49. Arlehamn, C.S.L.; Gerasimova, A.; Mele, F.; Henderson, R.; Swann, J.; Greenbaum, J.A.; Kim, Y.; Sidney, J.; James, E.A.; Taplitz, R.; et al. Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset. PLoS Pathog. 2013, 9, e1003130.
  50. Bansal, K.; Elluru, S.R.; Narayana, Y.; Chaturvedi, R.; Patil, S.A.; Kaveri, S.V.; Bayry, J.; Balaji, K.N. PE_PGRS Antigens of Mycobacterium tuberculosisInduce Maturation and Activation of Human Dendritic Cells. J. Immunol. 2010, 184, 3495–3504.
  51. Cohen, I.; Parada, C.; Acosta-Gão, E.; Espitia, C. The PGRS Domain from PE_PGRS33 of Mycobacterium tuberculosis is Target of Humoral Immune Response in Mice and Humans. Front. Immunol. 2014, 5, 236.
  52. Singh, P.P.; Parra, M.; Cadieux, N.; Brennan, M.J. A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins. Microbiology 2008, 154, 3469–3479.
  53. Chatrath, S.; Gupta, V.K.; Dixit, A.; Garg, L.C. The Rv1651c-encoded PE-PGRS30 protein expressed in Mycobacterium smegmatis exhibits polar localization and modulates its growth profile. FEMS Microbiol. Lett. 2011, 322, 194–199.
  54. Dheenadhayalan, V.; Delogu, G.; Brennan, M.J. Expression of the PE_PGRS 33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival. Microbes Infect. 2006, 8, 262–272.
  55. Dheenadhayalan, V.; Delogu, G.; Sanguinetti, M.; Fadda, G.; Brennan, M.J. Variable Expression Patterns of Mycobacterium tuberculosis PE_PGRS Genes: Evidence that PE_PGRS16 and PE_PGRS26 Are Inversely Regulated In Vivo. J. Bacteriol. 2006, 188, 3721–3725.
  56. Chakhaiyar, P.; Nagalakshmi, Y.; Aruna, B.; Murthy, K.J.R.; Katoch, V.M.; Hasnain, S.E. Regions of High Antigenicity within the Hypothetical PPE Major Polymorphic Tandem Repeat Open-Reading Frame, Rv2608, Show a Differential Humoral Response and a Low T Cell Response in Various Categories of Patients with Tuberculosis. J. Infect. Dis. 2004, 190, 1237–1244.
  57. Dillon, D.C.; Alderson, M.R.; Day, C.H.; Lewinsohn, D.; Coler, R.; Bement, T.; Campos-Neto, A.; Skeiky, Y.A.W.; Orme, I.M.; Roberts, A.; et al. Molecular Characterization and Human T-Cell Responses to a Member of a Novel Mycobacterium tuberculosis mtb39 Gene Family. Infect. Immun. 1999, 67, 2941–2950.
  58. Bonanni, D.; Rindi, L.; Lari, N.; Garzelli, C. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. J. Med. Microbiol. 2005, 54, 443–448.
  59. Sharma, T.; Grover, S.; Arora, N.; Manjunath, P.; Ehtesham, N.Z.; Hasnain, S.E. PGRS Domain of Rv0297 of Mycobacterium tuberculosis Is Involved in Modulation of Macrophage Functions to Favor Bacterial Persistence. Front. Cell. Infect. Microbiol. 2020, 10, 451.
  60. Sharma, T.; Singh, J.; Grover, S.; Manjunath, P.; Firdos, F.; Alam, A.; Ehtesham, N.Z.; Hasnain, S.E. PGRS Domain of Rv0297 of Mycobacterium tuberculosis Functions in A Calcium Dependent Manner. Int. J. Mol. Sci. 2021, 22, 9390.
  61. Ates, L.S.; Sayes, F.; Frigui, W.; Ummels, R.; Damen, M.P.M.; Bottai, D.; Behr, M.A.; van Heijst, J.W.J.; Bitter, W.; Majlessi, L.; et al. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection. PLoS Pathog. 2018, 14, e1007139.
  62. Abo-Kadoum, M.; Assad, M.; Ali, K.; Uae, M.; Nzaou, S.A.; Gong, Z.; Moaaz, A.; Lambert, N.; Eltoukhy, A.; Xie, J. Mycobacterium tuberculosis PE17 (Rv1646) promotes host cell apoptosis via host chromatin remodeling mediated by reduced H3K9me3 occupancy. Microb. Pathog. 2021, 159, 105147.
  63. Yi, F.; Hu, J.; Zhu, X.; Wang, Y.; Yu, Q.; Deng, J.; Huang, X.; Ma, Y.; Xie, Y. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated with Type I Interferon Signaling. Front. Cell. Infect. Microbiol. 2021, 11, 762.
  64. Sharma, N.; Shariq, M.; Quadir, N.; Singh, J.; Sheikh, J.A.; Hasnain, S.E.; Ehtesham, N.Z. Mycobacterium tuberculosis Protein PE6 (Rv0335c), a Novel TLR4 Agonist, Evokes an Inflammatory Response and Modulates the Cell Death Pathways in Macrophages to Enhance Intracellular Survival. Front. Immunol. 2021, 12, 696491.
  65. Ali, K.; Zhen, G.; Nzungize, L.; Stojkoska, A.; Duan, X.; Li, C.; Duan, W.; Xu, J.; Xie, J. Mycobacterium tuberculosis PE31 (Rv3477) Attenuates Host Cell Apoptosis and Promotes Recombinant, M. smegmatis Intracellular Survival via Up-regulating GTPase Guanylate Binding Protein-1. Front. Cell. Infect. Microbiol. 2020, 10, 40.
  66. Li, H.; Li, Q.; Yu, Z.; Zhou, M.; Xie, J. Mycobacterium tuberculosis PE13 (Rv1195) manipulates the host cell fate via p38-ERK-NF-κB axis and apoptosis. Apoptosis 2016, 21, 795–808.
  67. Kim, W.S.; Kim, J.-S.; Bin Cha, S.; Kim, S.J.; Kim, H.; Kwon, K.W.; Han, S.J.; Choi, S.Y.; Shin, S.J. Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection. Immunobiology 2015, 221, 440–453.
  68. Deng, W.; Zeng, J.; Xiang, X.; Li, P.; Xie, J. PE11 (Rv1169c) selectively alters fatty acid components of Mycobacterium smegmatis and host cell interleukin-6 level accompanied with cell death. Front. Microbiol. 2015, 6, 613.
  69. Tiwari, B.M.; Kannan, N.; Vemu, L.; Raghunand, T.R. The Mycobacterium tuberculosis PE Proteins Rv0285 and Rv1386 Modulate Innate Immunity and Mediate Bacillary Survival in Macrophages. PLoS ONE 2012, 7, e51686.
  70. Dolasia, K.; Nazar, F.; Mukhopadhyay, S. Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice. Eur. J. Immunol. 2020, 51, 603–619.
  71. Qureshi, R.; Rameshwaram, N.R.; Battu, M.B.; Mukhopadhyay, S. PPE65 of M. tuberculosis regulate pro-inflammatory signalling through LRR domains of Toll like receptor-2. Biochem. Biophys. Res. Commun. 2018, 508, 152–158.
  72. Xu, Y.; Yang, E.; Huang, Q.; Ni, W.; Kong, C.; Liu, G.; Li, G.; Su, H.; Wang, H. PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2. J. Mol. Med. 2015, 93, 645–662.
  73. Su, H.; Kong, C.; Zhu, L.; Huang, Q.; Luo, L.; Wang, H.; Xu, Y. PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response. Oncotarget 2015, 6, 38517–38537.
  74. Gong, Z.; Kuang, Z.; Li, H.; Li, C.; Ali, M.K.; Huang, F.; Li, P.; Li, Q.; Huang, X.; Ren, S. Regulation of host cell pyroptosis and cytokines production by Mycobacterium tuberculosis effector PPE60 requires LUBAC mediated NF-κB signaling. Cell. Immunol. 2019, 335, 41–50.
  75. Su, H.; Zhang, Z.; Liu, Z.; Peng, B.; Kong, C.; Wang, H.; Zhang, Z.; Xu, Y. Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2–dependent maturation of dendritic cells. J. Biol. Chem. 2018, 293, 10287–10302.
  76. Peng, X.; Luo, T.; Zhai, X.; Zhang, C.; Suo, J.; Ma, P.; Wang, C.; Bao, L. PPE11 of Mycobacterium tuberculosis can alter host inflammatory response and trigger cell death. Microb. Pathog. 2018, 126, 45–55.
  77. Yang, G.; Luo, T.; Sun, C.; Yuan, J.; Peng, X.; Zhang, C.; Zhai, X.; Bao, L. PPE27 in Mycobacterium smegmatis Enhances Mycobacterial Survival and Manipulates Cytokine Secretion in Mouse Macrophages. J. Interf. Cytokine Res. 2017, 37, 421–431.
  78. Yu, Z.; Zhang, C.; Zhou, M.; Li, Q.; Li, H.; Duan, W.; Li, X.; Feng, Y.; Xie, J. Mycobacterium tuberculosis PPE44 (Rv2770c) is involved in response to multiple stresses and promotes the macrophage expression of IL-12 p40 and IL-6 via the p38, ERK, and NF-κB signaling axis. Int. Immunopharmacol. 2017, 50, 319–329.
  79. Gallant, J.; Heunis, T.; Beltran, C.; Schildermans, K.; Bruijns, S.; Mertens, I.; Bitter, W.; Sampson, S.L. PPE38-Secretion-Dependent Proteins of M. tuberculosis Alter NF-kB Signalling and Inflammatory Responses in Macrophages. Front. Immunol. 2021, 12, 2440.
  80. Asaad, M.; Ali, M.K.; Abo-Kadoum, M.; Lambert, N.; Gong, Z.; Wang, H.; Uae, M.; Nazou, S.A.; Kuang, Z.; Xie, J. Mycobacterium tuberculosis PPE10 (Rv0442c) alters host cell apoptosis and cytokine profile via linear ubiquitin chain assembly complex HOIP-NF-κB signaling axis. Int. Immunopharmacol. 2021, 94, 107363.
  81. Deng, W.; Yang, W.; Zeng, J.; Abdalla, A.E.; Xie, J. Mycobacterium tuberculosis PPE32 promotes cytokines production and host cell apoptosis through caspase cascade accompanying with enhanced ER stress response. Oncotarget 2016, 7, 67347–67359.
  82. Deng, W.; Long, Q.; Zeng, J.; Li, P.; Yang, W.; Chen, X.; Xie, J. Mycobacterium tuberculosis PE_PGRS41 Enhances the Intracellular Survival of M. smegmatis within Macrophages Via Blocking Innate Immunity and Inhibition of Host Defense. Sci. Rep. 2017, 7, 46716.
  83. Yang, W.; Deng, W.; Zeng, J.; Ren, S.; Ali, K.; Gu, Y.; Li, Y.; Xie, J. Mycobacterium tuberculosis PE_PGRS18 enhances the intracellular survival of M. smegmatis via altering host macrophage cytokine profiling and attenuating the cell apoptosis. Apoptosis 2016, 22, 502–509.
  84. Basu, S.; Pathak, S.K.; Banerjee, A.; Pathak, S.; Bhattacharyya, A.; Yang, Z.; Talarico, S.; Kundu, M.; Basu, J. Execution of Macrophage Apoptosis by PE_PGRS33 of Mycobacterium tuberculosis Is Mediated by Toll-like Receptor 2-dependent Release of Tumor Necrosis Factor-α. J. Biol. Chem. 2007, 282, 1039–1050.
  85. Koh, K.W.; Soh, S.E.; Seah, G.T. Strong Antibody Responses to Mycobacterium tuberculosis PE-PGRS62 Protein Are Associated with Latent and Active Tuberculosis. Infect. Immun. 2009, 77, 3337–3343.
  86. Khubaib, M.; Sheikh, J.A.; Pandey, S.; Srikanth, B.; Bhuwan, M.; Khan, N.; Hasnain, S.E.; Ehtesham, N.Z. Mycobacterium tuberculosis Co-operonic PE32/PPE65 Proteins Alter Host Immune Responses by Hampering Th1 Response. Front. Microbiol. 2016, 7, 719.
  87. Riley, R.; Pellegrini, M.; Eisenberg, D. Identifying cognate binding pairs among a large set of paralogs: The case of PE/PPE Proteins of Mycobacterium tuberculosis. PLoS Commpuattional Biol. 2008, 4, e1000174.
  88. Tundup, S.; Mohareer, K.; Hasnain, S.E. Mycobacterium tuberculosisPE25/PPE41 protein complex induces necrosis in macrophages: Role in virulence and disease reactivation? FEBS Open Bio 2014, 4, 822–828.
  89. Tiwari, B.; Sorry, A.; Raghunand, T.R. An immunomodulatory role for the M ycobacterium tuberculosis region of difference 1 locus proteins PE 35 (R v3872) and PPE 68 (R v3873). FEBS J. 2014, 281, 1556–1570.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
ScholarVision Creations
Feedback